Thyroid orbitopathy (also known as Graves’ Disease) is an autoimmune inflammatory disorder of uncertain etiology that affects the tissues of the orbit (i.e. eyelids, extraocular muscles and other soft tissues surrounding the eyes). Patients with this disorder often have an associated thyroid abnormality which may manifest either before, during or after the orbital signs and symptoms. However, a small percentage of patients may have eyelid and orbital manifestations of the disorder without developing a thyroid abnormality.
Thyroid orbitopathy can develop and affect patients with varying degrees of severity. The disease can begin suddenly and progress rapidly over days to weeks or start insidiously and progress gradually over a long period of time. The majority of patients have mild inflammation, the most common signs and symptoms of which are retraction of the upper and/or lower eyelids and bulging of the eyes (also known as proptosis). In cases of moderate inflammation, patients may also have varying degrees of double vision and eyelid swelling as well as visible redness of the lids and eyes. A small percentage of patients with thyroid eye disease develop severe inflammation, which can result in compression of the optic nerve and permanent vision loss. In most cases, the inflammatory process is self-limited and runs a course lasting 6 months to a few years before subsiding. After the inflammatory phase of the disease subsides, scarring of eyelid and orbital tissues may result in the persistence of eyelid retraction, proptosis and double vision.
It is important to be evaluated by an oculoplastic specialist like Dr. Fu to assess the ophthalmic manifestations of the disease, as well as by an endocrinologist to manage concurrent thyroid abnormalities. Patients with mild orbitopathy are usually evaluated on an interval basis to monitor progression of the disease and managed with measures to reduce ocular symptoms. Patients with moderate to severe orbitopathy may require medical or surgical intervention to reduce inflammation or improve vision. Once the inflammatory phase of the disease has subsided, patients with eyelid abnormalities, double-vision or proptosis may be eligible for surgical correction to improve their function and appearance. Cigarette smoking has been associated with development of worsening thyroid orbitopathy, therefore cessation of smoking is universally recommended in these patients.
As a board-certified, fellowship trained oculoplastic surgeon with extensive training and experience, Dr. Selena Fu customizes each treatment to reflect each patient’s unique anatomy, skin condition, aesthetic concerns and lifestyle— an approach that consistently delivers excellent results for her patients.
Call for a personal consultation today, Dr. Fu will discuss the surgical and non-surgical options that will provide your best possible outcome. Insurance may cover all or a portion of reconstructive surgeries.
Thyroid Orbitopathy, also known as Thyroid Eye Disease (TED) or Graves’ Orbitopathy, is an autoimmune condition that affects the eye and surrounding tissues. It causes eye bulging (proptosis), eyelid retraction, double vision, dryness, and irritation due to inflammation in the eye socket. While some severe cases may require surgery, many patients can manage their symptoms with non-surgical treatments.
Most non-surgical treatments focus on reducing inflammation, managing symptoms, and preventing long-term damage.
If TED causes double vision (diplopia), special prism lenses can help align images and improve vision without surgery.
Low-dose orbital radiation may be used to reduce swelling and eye muscle inflammation, especially when steroids alone are not effective.
If non-surgical treatments do not control the symptoms or the patient is left with significant eye bulging, double vision, or eyelid problems, surgery may be necessary after the disease has stabilized.
Thyroid Orbitopathy, also known as Thyroid Eye Disease (TED) or Graves’ Orbitopathy, is an autoimmune condition that causes inflammation, swelling, and tissue expansion behind the eye, leading to bulging eyes (proptosis), double vision, eyelid retraction, and, in severe cases, vision loss. When non-surgical treatments are not enough to correct vision problems or cosmetic concerns, surgical intervention may be necessary.
Surgery is usually considered once TED has stabilized (inactive phase), which typically occurs 6 months to 2 years after the active inflammation phase. Surgery may be needed if:
Surgery is usually performed in three stages, depending on the severity of the disease:
Most TED cases remain stable after surgery, but if thyroid levels fluctuate or smoking continues, symptoms may return.
If you experience severe eye bulging, double vision, or eyelid problems due to thyroid eye disease, consult an oculoplastic surgeon or orbital specialist to explore surgical treatment options.
Thyroid Orbitopathy, also known as Thyroid Eye Disease (TED) or Graves’ Orbitopathy, is an autoimmune condition where the immune system mistakenly attacks the tissues around the eyes. This leads to inflammation, swelling, and tissue expansion, causing symptoms like eye bulging (proptosis), double vision, eyelid retraction, and eye discomfort.
TED is mainly caused by an overactive thyroid due to Graves’ Disease. However, some cases occur in patients with normal or underactive thyroid function. Factors that contribute to TED include:
Overactive thyroid (Hyperthyroidism/Graves’ Disease) – The most common cause.
Smoking – Greatly increases the risk and severity of TED.
Autoimmune response – The body mistakenly attacks tissues around the eyes.
Genetics – Family history may play a role.
A doctor may perform:
Physical Eye Exam – To check for swelling, redness, eye movement, and bulging.
Imaging Tests (CT/MRI) – To assess the swelling and pressure behind the eyes.
Thyroid Blood Tests – To check thyroid hormone levels (TSH, T3, T4, and thyroid antibodies).
There is no cure, but treatments can manage symptoms, reduce inflammation, and prevent vision loss.
TED treatment depends on whether the disease is active (inflamed phase) or stable (chronic phase).
Yes, but it is more common for TED to affect both eyes. One eye may have more severe symptoms than the other.
If severe TED is not treated, it can lead to:
Most insurance plans cover TED treatments, including:
Yes, TED can relapse, especially if thyroid levels are not well controlled or the patient continues smoking.
If you experience eye bulging, double vision, or eye discomfort, consult an oculoplastic surgeon or endocrinologist to discuss treatment options.